ストックスクリーナーアプリを入手
1.61
1.83%
-0.03
アフターアワーズ：
1.66
0.05
+3.11%
前日終値:
$1.64
開ける：
$1.64
24時間の取引高:
1.63M
Relative Volume:
0.53
時価総額：
$329.96M
収益：
$12.87M
当期純損益:
$-114.34M
株価収益率:
-1.8621
EPS:
-0.8646
ネットキャッシュフロー:
$-79.23M
1週間 パフォーマンス:
-1.23%
1か月 パフォーマンス:
+5.23%
6か月 パフォーマンス:
-28.76%
1年 パフォーマンス:
-36.11%
1日の値動き範囲:
$1.60
$1.71
1週間の範囲:
$1.58
$1.74
52週間の値動き範囲:
$1.19
$4.32
Taysha Gene Therapies Inc Stock (TSHA) Company Profile
名前
Taysha Gene Therapies Inc
セクター
電話
(214) 612-0000
住所
3000 PEGASUS PARK DRIVE, DALLAS
TSHA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TSHA
Taysha Gene Therapies Inc
|
1.61 | 329.96M | 12.87M | -114.34M | -79.23M | -0.8646 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-27 | 開始されました | BMO Capital Markets | Outperform |
| 2024-04-09 | 開始されました | Piper Sandler | Overweight |
| 2023-02-01 | ダウングレード | Jefferies | Buy → Hold |
| 2023-01-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-09 | ダウングレード | Goldman | Buy → Neutral |
| 2022-03-09 | 開始されました | Robert W. Baird | Outperform |
| 2022-03-01 | 開始されました | Wells Fargo | Overweight |
| 2022-02-18 | 開始されました | SMBC Nikko | Outperform |
| 2021-12-16 | 開始されました | Guggenheim | Buy |
| 2021-07-16 | 開始されました | Needham | Buy |
| 2021-06-24 | 開始されました | Truist | Buy |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-06-09 | 開始されました | Wedbush | Outperform |
| 2021-06-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-05-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-05-11 | 再開されました | Jefferies | Buy |
| 2021-02-24 | 開始されました | William Blair | Outperform |
| 2021-01-05 | 開始されました | Oppenheimer | Outperform |
| 2020-10-19 | 開始されました | Chardan Capital Markets | Buy |
| 2020-10-19 | 開始されました | Goldman | Buy |
| 2020-10-19 | 開始されました | Jefferies | Buy |
| 2020-10-19 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Taysha Gene Therapies Inc (TSHA) 最新ニュース
Taysha Gene Therapies (TSHA) Projected to Post Earnings on Wednesday - Defense World
Taysha Gene Therapies to Release Full-Year 2024 Financial - GlobeNewswire
Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26 - The Manila Times
Gene Therapy Pioneer Taysha Readies Crucial 2024 Financial DisclosureHere's When - StockTitan
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Brokerages - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by SG Americas Securities LLC - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 1.3%Time to Buy? - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Critical Analysis: Creative Medical Technology (NASDAQ:CELZ) vs. Taysha Gene Therapies (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Taysha Gene Therapies Inc (TSHA) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks
Taysha Gene Therapies Inc [TSHA] Records 50-Day SMA of $1.9835 - Knox Daily
Taysha's Strategic Move: 491K Stock Options Awarded to Secure Top Industry Talent - StockTitan
Rett Syndrome Market Growth Projections 2024-2034: - openPR
Prepare Yourself for Liftoff: Taysha Gene Therapies Inc (TSHA) - SETE News
Octagon Capital Advisors LP Increases Stake in Taysha Gene Thera - GuruFocus.com
Scienjoy Holding Leads Our 3 US Penny Stocks To Consider - Simply Wall St
Taysha Gene Therapies Inc (TSHA)’s Market Momentum: Closing Strong at 1.53, Up 2.00 - The Dwinnex
Technical analysis of Taysha Gene Therapies Inc (TSHA) stock chart patterns - US Post News
Taysha Gene Therapies Is Showing Promise For Rett Syndrome - Seeking Alpha
Cantor Fitzgerald Predicts TSHA FY2025 Earnings - Defense World
Brokers Issue Forecasts for TSHA FY2025 Earnings - MarketBeat
Illuminating Rett syndrome: Latest pharmacological advancements - The Pharma Letter
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) PT at $6.63 - MarketBeat
Barclays PLC Increases Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Barclays PLC Boosts Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Jane Street Group LLC Sells 20,552 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Principal Financial Group Inc. Sells 5,810 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Given “Buy” Rating at Needham & Company LLC - Defense World
Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts - Benzinga
Taysha Gene Therapies' (TSHA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Acelyrin Leads The Charge With 2 Other US Penny Stocks - Yahoo Finance
Taysha Gene Therapies Grants 311,000 Stock Options to New Employee Under Inducement Plan - StockTitan
100,795 Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Bought by Franklin Resources Inc. - Defense World
Barclays PLC Buys 193,046 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Geode Capital Management LLC Acquires 682,273 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Geode Capital Management LLC Buys 682,273 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Short Interest Update - MarketBeat
State Street Corp Has $6.97 Million Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Wellington Management Group LLP Buys New Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
The Manufacturers Life Insurance Company Sells 72,548 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies' SWOT analysis: promising rett syndrome stock faces key tests - Investing.com Canada
Thinking about buying stock in Nikola, Delcath Systems, Taysha G - GuruFocus.com
Fmr LLC Has $37.54 Million Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by Fmr LLC - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 6.3%Still a Buy? - MarketBeat
Taysha Gene Therapies Inc (TSHA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):